New PET tracer aims to spot aggressive breast cancer – study halted before start
NCT ID NCT05634954
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study was designed to test a new radioactive tracer called [18F]GEH121224 for PET scans in people with advanced HER2-positive breast cancer. The goal was to see if it could safely and accurately detect cancer spread. The study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas MD Anderson Cancer Centre
Houston, Texas, 77030-4008, United States
Conditions
Explore the condition pages connected to this study.